ConductScience.org, home

Trial · NCT00662714

Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis

NCT00662714, Phase 3, Completed, Mukoviszidose Institut gGmbH

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis. Trials, record NCT00662714. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00662714

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis
NCT number
NCT00662714
Status
Completed
Phases
Phase 3
Enrollment
73 participants, actual
Lead sponsor
Mukoviszidose Institut gGmbH
Conditions
Cystic Fibrosis, Diabetes Mellitus
Interventions
Repaglinide, short-acting Insulin (Actrapid)
First posted
2008-04-21
Last updated
2012-07-10

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryHbA1c2 years

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
23809507DERIVEDPubMed
24620855DERIVEDPubMed
29199116DERIVEDPubMed
33075159DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00662714

GET https://conductscience.org/api/trials/v1/NCT00662714/registered